In the News
Pacific Biosciences, provider of the PacBio RS II DNA Sequencing System, is partnering with the Wellcome Trust Sanger Institute and Public Health England to complete the sequences of 3,000 bacterial genome strains.
Research from Weill Cornell Medical College shows that someday damaged or diseased organs may be healed with an injection of blood vessel cells, eliminating the need for donated organs and transplants.
Optofluidics was named a finalist in the Life Science and Biophotonics category for the 2014 Prism Awards for Photonics Innovation, “a competition recognizing new products and inventions that break with conventional ideas, solve problems, and improve life through the generation and application of light-based technologies, optics and photonics.”
To provide a corporate leg up to technology opportunities and startup companies emerging from research here, the new Cornell Technology Acceleration and Maturation (C-TAM) program is designed to propel promising ideas toward commercial viability.
Cornell study opens a path for new drugs to block brain tumor growth with fewer side effects and lower resistance rates than most conventional cancer drugs.
BinOptics, a manufacturer and supplier of semiconductor lasers for optical connectivity, ranked 167 on Deloitte’s Technology Fast 500™, a ranking of the 500 fastest growing technology, media, telecommunications, life sciences and clean technology companies in North America.
Starchy, filling, high in vitamins and minerals, potatoes serve as comfort food, fun food, a major source of nutrition, and the basis for serious cuisine. And just as chefs continue to explore and expand the repertoire of potato possibilities, plant breeders continue to breed for improved qualities.
In a Letter to the Editor, Vice Provost and CCTEC Executive Director, Alan Paau, responds to an article in the Cornell Daily Sun about Cornell's 'Startup Problem'.
New York's largest producing wine region, the Finger Lakes has more than 100 wineries dotting the panoramic hills around the lakes.
Scientists from The Scripps Research Institute (TSRI) and Weill Cornell Medical College have completed a new analysis of a key AIDS protein long considered to be one of the most difficult targets in structural biology, and their work is an important step forward in the development of an HIV vaccine.
For archived news items, click here.